RATIONALE: There is continued interest in exploring new analytical technologies for the detection and quantitation of DNA adducts, biomarkers which provide direct evidence of exposure and genetic damage in cells. With the goal of reducing clean-up steps and improving sample throughput, a Differential Mobility Spectrometry/Mass Spectrometry (DMS/MS) platform has been introduced for adduct analysis. METHODS: A DMS/MS platform has been utilized for the analysis of dG-ABP, the deoxyguanosine adduct of the bladder carcinogen 4-aminobiphenyl (4-ABP). After optimization of the DMS parameters, each sample was analyzed in just 30 s following a simple protein precipitation step of the digested DNA. RESULTS: A detection limit of one modification in 10^6 nucleosides has been achieved using only 2 µg of DNA. A brief comparison (quantitative and qualitative) with liquid chromatography/mass spectrometry is also presented highlighting the advantages of using the DMS/MS method as a high-throughput platform. CONCLUSIONS: The data presented demonstrate the successful application of a DMS/MS/MS platform for the rapid quantitation of DNA adducts using, as a model analyte, the deoxyguanosine adduct of the bladder carcinogen 4-aminobiphenyl.
RATIONALE: There is continued interest in exploring new analytical technologies for the detection and quantitation of DNA adducts, biomarkers which provide direct evidence of exposure and genetic damage in cells. With the goal of reducing clean-up steps and improving sample throughput, a Differential Mobility Spectrometry/Mass Spectrometry (DMS/MS) platform has been introduced for adduct analysis. METHODS: A DMS/MS platform has been utilized for the analysis of dG-ABP, the deoxyguanosine adduct of the bladder carcinogen 4-aminobiphenyl (4-ABP). After optimization of the DMS parameters, each sample was analyzed in just 30 s following a simple protein precipitation step of the digested DNA. RESULTS: A detection limit of one modification in 10^6 nucleosides has been achieved using only 2 µg of DNA. A brief comparison (quantitative and qualitative) with liquid chromatography/mass spectrometry is also presented highlighting the advantages of using the DMS/MS method as a high-throughput platform. CONCLUSIONS: The data presented demonstrate the successful application of a DMS/MS/MS platform for the rapid quantitation of DNA adducts using, as a model analyte, the deoxyguanosine adduct of the bladder carcinogen 4-aminobiphenyl.
Authors: Yi Ding; Joseph D Paonessa; Kristen L Randall; Dayana Argoti; Lihua Chen; Paul Vouros; Yuesheng Zhang Journal: Carcinogenesis Date: 2010-09-01 Impact factor: 4.944
Authors: Elaine M Ricicki; John R Soglia; Candee Teitel; Robert Kane; Fred Kadlubar; Paul Vouros Journal: Chem Res Toxicol Date: 2005-04 Impact factor: 3.739
Authors: Robert J Turesky; James P Freeman; Ricky D Holland; Daniel M Nestorick; Dwight W Miller; D Luke Ratnasinghe; Fred F Kadlubar Journal: Chem Res Toxicol Date: 2003-09 Impact factor: 3.739
Authors: Kristen L Randall; Dayana Argoti; Joseph D Paonessa; Yi Ding; Zachary Oaks; Yuesheng Zhang; Paul Vouros Journal: J Chromatogr A Date: 2009-11-10 Impact factor: 4.759
Authors: Zhidan Chen; Stephen L Coy; Evan L Pannkuk; Evagelia C Laiakis; Adam B Hall; Albert J Fornace; Paul Vouros Journal: J Am Soc Mass Spectrom Date: 2016-07-08 Impact factor: 3.109
Authors: Zhidan Chen; Stephen L Coy; Evan L Pannkuk; Evagelia C Laiakis; Albert J Fornace; Paul Vouros Journal: J Am Soc Mass Spectrom Date: 2018-05-07 Impact factor: 3.109
Authors: Amol Kafle; Stephen L Coy; Bryan M Wong; Albert J Fornace; James J Glick; Paul Vouros Journal: J Am Soc Mass Spectrom Date: 2014-01-23 Impact factor: 3.109
Authors: Nicholas B Vera; Stephen L Coy; Evagelia C Laiakis; Albert J Fornace; Michelle Clasquin; Christopher A Barker; Jeffrey A Pfefferkorn; Paul Vouros Journal: J Am Soc Mass Spectrom Date: 2020-01-28 Impact factor: 3.109
Authors: Joshua J Klaene; Caroline Flarakos; James Glick; Jennifer T Barret; Helmut Zarbl; Paul Vouros Journal: J Chromatogr A Date: 2015-10-26 Impact factor: 4.759